We are live on ! Find out more
Antipodes Partners

Antipodes Partners Portfolio holdings

AUM $5.46B Turnover 36.94%
1-Year Est. Return 26.64%
This Fund
S&P 500
This Quarter Est. Return
+4.52%
1 Year Est. Return
+26.64%
3 Year Est. Return
+96.4%
5 Year Est. Return
+160.76%
10 Year Est. Return
–
AUM
$5.19B
AUM Growth
+$431M
Cap. Flow
+$355M
Cap. Flow %
6.83%
Top 10 Hldgs %
35.34%
Holding
153
New
23
Increased
48
Reduced
47
Closed
27
Avg Time Held Equity + Options
1.1 years
Top 10 Avg Time Held Equity + Options
1.7 years
Top 20 Avg Time Held Equity + Options
1.8 years
Avg Time Held Equity only
1.1 years
Top 10 Avg Time Held Equity only
1.7 years
Top 20 Avg Time Held Equity only
1.8 years

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$130M
2
HTO icon
H2O America
HTO
+$102M
3
DIS icon
Walt Disney
DIS
+$69.5M
4
WDAY icon
Workday
WDAY
+$69M
5
PGR icon
Progressive
PGR
+$60.7M

Sector Composition

Rank Sector Weight
1 Utilities 28.74%
2 Technology 13.47%
3 Healthcare 12.72%
4 Energy 9.26%
5 Consumer Discretionary 8.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ANL icon
126
Adlai Nortye Group ADS
ANL
$743M
$14.2K ﹤0.01%
+2,051
New +$13.7K
2026 Q1
0 quarters
ALLY icon
127
CALL
Ally Financial
ALLY
$11.6B
– –
-8,935
Closed -$760K –
AMD icon
128
Advanced Micro Devices
AMD
$895B
– –
-293,078
Closed -$62.8M –
APGE icon
129
DELISTED
Apogee Therapeutics
APGE
– –
-723
Closed -$54.6K –
ARRY icon
130
Array Technologies
ARRY
$548M
– –
-1,715
Closed -$15.8K –
ASHR icon
131
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.33B
– –
-56,694
Closed -$1.86M –
CENX icon
132
Century Aluminum
CENX
$3.58B
– –
-423,789
Closed -$16.6M –
DAWN icon
133
DELISTED
Day One Biopharmaceuticals
DAWN
– –
-2,559
Closed -$23.9K –
ESTA icon
134
Establishment Labs
ESTA
$1.8B
– –
-969
Closed -$70.6K –
FOLD icon
135
DELISTED
Amicus Therapeutics
FOLD
– –
-3,926
Closed -$55.9K –
GPCR icon
136
PUT
Structure Therapeutics
GPCR
$1.54B
– –
-48
Closed -$30K –
GTLB icon
137
GitLab
GTLB
$8.99B
– –
-27,433
Closed -$1.03M –
HON icon
138
CALL
Honeywell
HON
$67.2B
– –
-2,067
Closed -$604K –
JANX icon
139
Janux Therapeutics
JANX
$1.03B
– –
-720
Closed -$9.94K –
KO icon
140
Coca-Cola
KO
$400B
– –
-145,423
Closed -$10.2M –
LEN icon
141
Lennar Class A
LEN
$18.5B
– –
-335,039
Closed -$34.4M –
LSPD icon
142
Lightspeed Commerce
LSPD
$1.4B
– –
-1,024,963
Closed -$12.4M –
MDT icon
143
Medtronic
MDT
$122B
– –
-730
Closed -$70.1K –
MGNI icon
144
Magnite
MGNI
$3.51B
– –
-24,831
Closed -$403K –
MNDY icon
145
monday.com
MNDY
$3.84B
– –
-2,381
Closed -$351K –
NE icon
146
Noble Corp
NE
$7.02B
– –
-257,244
Closed -$7.27M –
NOVT icon
147
Novanta
NOVT
$5.06B
– –
-449
Closed -$53.4K –
SG icon
148
Sweetgreen
SG
$1.26B
– –
-51,873
Closed -$351K –
SGMT icon
149
Sagimet Biosciences
SGMT
$584M
– –
-3,176
Closed -$18.8K –
SHLS icon
150
Shoals Technologies Group
SHLS
$1.28B
– –
-978
Closed -$8.31K –

Similar funds

Antipodes Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Antipodes Partners held 153 positions worth $5.19B, up 9.1% from $4.76B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Antipodes Partners deployed $355M of net new capital in Q1 2026, opening 23 new positions and adding to 48 existing holdings. Its largest new stake was NVIDIA: 710,665 shares worth $124M.

By sector, the portfolio is most concentrated in Utilities at 29% of assets, up from 26% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $53.2M trimmed.

  • Antipodes Partners's largest Q1 2026 buy was NVIDIA: 710,665 shares worth $124M.
  • Antipodes Partners added most to H2O America in Q1 2026, an estimated $102M increase.
  • Antipodes Partners's biggest Q1 2026 reduction was Meta Platforms (Facebook), cutting an estimated $53.2M.
  • Antipodes Partners fully exited Advanced Micro Devices in Q1 2026, selling an estimated $62.8M.
  • Antipodes Partners's ten largest holdings make up 35% of its $5.19B portfolio in Q1 2026.
  • Antipodes Partners opened 23 new positions and closed 27 in Q1 2026.
  • Antipodes Partners's portfolio value rose 9.1% quarter-over-quarter to $5.19B.

Based on Antipodes Partners's 13F filing for Q1 2026, filed 5 May 2026.